Hypertension is one of the most prevalent chronic diseases in China. As of 2021, there are over 270 million people suffering from hypertension in our country, which is the most significant risk factor for the death of urban and rural residents due to cardiovascular and cerebrovascular diseases. China has now entered the stage of comprehensively building a Healthy China, and exploring the construction of a chronic disease management path with the integration of healthcare and prevention as the core has become an important trend. This specification is based on the existing content and process of hypertension integration of healthcare and prevention services, and formulates standardized service diagnostic and treatment norms for the integration of hypertension healthcare and prevention. The content of the specification mainly includes basic requirements for service provision, service content, service process, etc., aiming to optimize the primary diagnosis and treatment and health management process of hypertension, control the incidence and mortality of hypertension, and reduce and delay the occurrence of complications, thereby effectively building a primary prevention and treatment line for chronic diseases.

高血压是我国最常见的慢性病之一。截至2021年，我国高血压患者超过2.7亿人，高血压已成为导致我国城乡居民心脑血管疾病死亡的最主要的危险因素。我国现已进入全面建设健康中国阶段，探索构建以医防融合为核心的慢性病管理路径成为重要趋势。本规范以现有高血压医防融合服务内容与服务流程为基础，制定高血压医防融合规范化服务诊疗规范，规范主要包括服务提供基本要求、服务内容、服务流程等内容，旨在优化高血压的基层诊疗和健康管理流程，控制高血压的发病率与死亡率，并减少和延缓并发症的发生，从而有效构筑基层慢病管理防治线。